Beat Biotherapeutics, A U Washington Start-up, Raises $2.5M For Heart Failure Treatment
Beat Biotherapeutics looked like it was in trouble after its co-founder and CEO died suddenly in June 2009. But the University of Washington spinout is definitely back in business, after recruiting a veteran CEO and raising another $2.5 million to advance an experimental treatment for heart failure.
$20 Million W Fund, Focusing on Research Spinouts, Open for Business
We’ve been hearing about a new investment fund for university spinouts in Washington state for close to two years. Starting today, the W Fund is officially ready to start cutting checks—and it’s already started investigating promising research projects from colleges and government R&D labs around the state.